PDL BioPharma Announces Conversion Rate Adjustment for 2.00% Convertible Senior Notes Due February 15, 2012 |
| September 13, 2010 | September 2010 Bond Updates |
|
INCLINE VILLAGE, Nev., Sept. 13 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced an adjustment to the conversion rate for its 2.00% Convertible Senior Notes due February 15, 2012 (the 2012 Notes) effective September 16, 2010 in connection with the special dividend t |
| View more at: http://www.prnewswire.com/news-releases/pdl-biopharma-announces-conversion-rate-adjustment-for-200-convertible-senior-notes-due-february-15-2012-102761794.html |
| Related News |
|